The basketball legend's protracted dispute in China encapsulates the challenges of trademark protection involving different cultures and languages
April 24, 2020
Legal
Bao Zhi, Yibei Zhang, Grace Tso and Scott Silverman of Baker McKenzie and FenXun Partners discuss the workings of the Negative List regime and other administrative measures that impact market access for foreign investments in the light of China's push to provide foreign investors with a fairer and more transparent foreign investment environment
April 24, 2020China's pandemic-hit economy contracts for first time in decades in Q1; Renault exits China joint-venture amid weak sales and worsening outlook; new national blockchain committee launched with several tech giants involved
April 20, 2020SAFE relaxes forex control to facilitate cross-border business, Guangdong issues guidelines on IP protection for online games and interbank interest rate options trading is launched.
April 17, 2020Shareholding requirements for non-bank financial institutions are tightened
April 17, 2020CSRC defines "strategic investors" in private offering of shares
April 17, 2020How has disruption to Chinese businesses and deals shifted as the virus itself has moved from China to the U.S.? Scott Yu and Meg Utterback discuss the pandemic's impact on international M&A, litigation, antitrust enforcement, and U.S. regulatory action against Chinese companies
April 16, 2020Bo Yan and Taoye Ye of Haiwen & Partners discuss CBIRC's amended rules governing the regulatory approvals of non-bank financial institutions, which lower the bar for foreign investment in national asset management companies
April 16, 2020U.S. agencies recommend stripping China Telecom of operating license over national security concerns; China knocks U.S. off top spot in global patent filing league table; and Chinese customs to increase checks on medical equipment exports amid complaints about low quality
April 13, 2020CSRC defines strategic investors in private offering of shares, quoting of defaulted bond trading is subject to regulation and CBIRC clarifies the scope of medical insurance products with revisable premium rates.
April 09, 2020
